Replies to post #295439 on NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

Once approved, the share price will skyrocket and they will have plenty of cash flowing in to rapidly scale up manufacturing. Once the cloud hanging over NWBO and the deluge of disinformation dissipate so that the public can see what it really can do and recognize that DCVAX is effectively a cure for roughly 30% of the GBM patients with none of the toxic side effects of chemo people will be pounding at the door to get treatment. The NIH and other organizations will be drenching them with grants to speed this up because the public will be demanding it. Perhaps Biden can now see his project moonshot that he imitated under Obama come to fruition. What did he do get a bunch of big pharma thugs at a table and said lets all play nice together, share data and cure cancer. What a joke he is. :-)

Any with DCVAX volume manufacturing give it a year and they will have the capability to treat thousands of patients a month. You'll see.

[Jack2479]

I think you are out on the numbers going to be treated per month - it’s being built to scale up. 30 to 40 per month is in line with what I learned for an initial operational start up. They currently treat way less than that out of a hospital in London.

Still needed work at the site but the sexy stuff - clean rooms etc were all finished. I respectfully disagree that the U.K. specials program will be a cash drain, I’d say quite the opposite.

[biosectinvestor]

The fact is, while it is not scaled in theory they could charge whatever they need to charge during that period to make it economically viable. That is how it always is, but the other reality is, from what others are saying, you’re vastly understating the potential.

Isn’t that to be expected of you? I really can’t imagine you ever being positive or enthusiastic except maybe for a moment to retain credibility where something is momentarily undeniable and before you’ve found some reason to criticize.

Do you really expect anyone to take that seriously.

Most of us are here ultimately to see a successful and economically sustainable business. If the treatment is selling and successful at all, there is no way that that is not ultimately achieved, given currently anticipated price points, regardless of your criticisms.